Header Logo

Connection

RACHEL SCHIFF to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications RACHEL SCHIFF has written about Drug Evaluation, Preclinical.
RACHEL SCHIFF
Connection Strength
0.053
Drug Evaluation, Preclinical
  1. Advances in breast cancer treatment and prevention: preclinical studies on aromatase inhibitors and new selective estrogen receptor modulators (SERMs). Breast Cancer Res. 2003; 5(5):228-31.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.